Alan C. Moss

9.6k total citations · 1 hit paper
192 papers, 6.8k citations indexed

About

Alan C. Moss is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Alan C. Moss has authored 192 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Genetics, 89 papers in Epidemiology and 55 papers in Surgery. Recurrent topics in Alan C. Moss's work include Inflammatory Bowel Disease (91 papers), Microscopic Colitis (78 papers) and Eosinophilic Esophagitis (18 papers). Alan C. Moss is often cited by papers focused on Inflammatory Bowel Disease (91 papers), Microscopic Colitis (78 papers) and Eosinophilic Esophagitis (18 papers). Alan C. Moss collaborates with scholars based in United States, Ireland and United Kingdom. Alan C. Moss's co-authors include Adam S. Cheifetz, Kavinderjit S. Nanda, Simon C. Robson, Garrett Lawlor, Eva Morris, Padraic MacMathúna, Maggie Ham, Francis A. Farraye, Joseph D. Feuerstein and John Gubatan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alan C. Moss

189 papers receiving 6.7k citations

Hit Papers

Ulcerative Colitis 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ulcerative Colitis
    2019 301 citations Alan C. Moss et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alan C. Moss 2.9k 2.5k 1.8k 1.2k 1.2k 192 6.8k
Pieter Stokkers 4.0k 1.4× 2.5k 1.0× 2.2k 1.2× 1.4k 1.2× 768 0.7× 133 6.4k
Bas Oldenburg 4.2k 1.4× 3.3k 1.3× 2.5k 1.4× 939 0.8× 999 0.8× 208 7.7k
Rupert W. Leong 3.6k 1.2× 3.0k 1.2× 3.0k 1.6× 1.1k 0.9× 2.2k 1.9× 336 9.6k
Jae Hee Cheon 2.6k 0.9× 2.5k 1.0× 3.0k 1.6× 1.6k 1.3× 1.8k 1.5× 422 9.7k
Miquel Sans 3.2k 1.1× 2.2k 0.9× 1.8k 1.0× 1.2k 1.0× 1.1k 0.9× 109 6.0k
Michael Scharl 2.7k 0.9× 1.9k 0.7× 1.7k 0.9× 1.5k 1.2× 2.8k 2.4× 245 7.1k
Fernando Magro 5.5k 1.9× 4.2k 1.7× 2.4k 1.3× 1.5k 1.2× 1.1k 0.9× 307 8.6k
Morten H. Vatn 4.8k 1.6× 4.2k 1.7× 2.9k 1.6× 837 0.7× 1.1k 0.9× 157 8.8k
Minhu Chen 1.8k 0.6× 1.4k 0.6× 1.7k 0.9× 780 0.6× 1.3k 1.1× 183 5.5k
Richard J. Grand 4.6k 1.6× 2.5k 1.0× 3.3k 1.8× 905 0.7× 1.4k 1.2× 224 10.1k

Countries citing papers authored by Alan C. Moss

Since Specialization
Citations

This map shows the geographic impact of Alan C. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. Moss more than expected).

Fields of papers citing papers by Alan C. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. Moss. The network helps show where Alan C. Moss may publish in the future.

Co-authorship network of co-authors of Alan C. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Alan C. Moss. A scholar is included among the top collaborators of Alan C. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan C. Moss. Alan C. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moss, Alan C., et al.. (2024). Medical management of painful achalasia: a patient-driven systematic review. Diseases of the Esophagus. 37(5). 1 indexed citations
2.
Tate, David J., Mayenaaz Sidhu, Sunil Gupta, et al.. (2023). The Surface Morphology of Large Nonpedunculated Colonic Polyps Predicts Synchronous Large Lesions. Clinical Gastroenterology and Hepatology. 21(9). 2270–2277.e1. 4 indexed citations
3.
Moss, Alan C., et al.. (2023). Speaker Diversity and Audience Ratings at a National Inflammatory Bowel Diseases Conference. Inflammatory Bowel Diseases. 30(1). 78–82. 1 indexed citations
4.
Andreou, Alexandros, Luigi Bonavina, Iván D. Flórez, et al.. (2022). UEG and EAES rapid guideline: Update systematic review, network meta‐analysis, CINeMA and GRADE assessment, and evidence‐informed European recommendations on surgical management of GERD. United European Gastroenterology Journal. 10(9). 983–998. 18 indexed citations
5.
Vosko, Sergei, Neal Shahidi, Mayenaaz Sidhu, et al.. (2021). Optical Evaluation for Predicting Cancer in Large Nonpedunculated Colorectal Polyps Is Accurate for Flat Lesions. Clinical Gastroenterology and Hepatology. 19(11). 2425–2434.e4. 20 indexed citations
6.
Mukherjee, Samiran, Marta Vuerich, Peter J. Cowan, et al.. (2019). Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn’s Disease. Journal of Crohn s and Colitis. 14(6). 818–830. 18 indexed citations
7.
Ballou, Sarah, William Hirsch, Prashant Singh, et al.. (2018). Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Alimentary Pharmacology & Therapeutics. 47(7). 913–921. 31 indexed citations
8.
Pellisé, María, Nicholas G. Burgess, Nicholas Tutticci, et al.. (2016). Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions. Gut. 66(4). 644–653. 91 indexed citations
9.
Mitsuhashi, Shuji, Linda Feldbrügge, Eva Csizmadia, et al.. (2016). Luminal Extracellular Vesicles (EVs) in Inflammatory Bowel Disease (IBD) Exhibit Proinflammatory Effects on Epithelial Cells and Macrophages. Inflammatory Bowel Diseases. 22(7). 1587–1595. 95 indexed citations
10.
Burgess, Nicholas G., María Pellisé, Kavinderjit S. Nanda, et al.. (2015). Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut. 65(3). 437–446. 65 indexed citations
11.
Schor, Nestor, et al.. (2013). Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cellular Immunology. 282(1). 66–70. 32 indexed citations
12.
Gifford, Anne E., Anders H. Berg, Conor Lahiff, et al.. (2013). A Random Urine Test Can Identify Patients at Risk of Mesalamine Non-Adherence: A Prospective Study. The American Journal of Gastroenterology. 108(2). 249–255. 20 indexed citations
13.
Moss, Alan C., et al.. (2012). Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. Clinical Pharmacology Advances and Applications. 4. 41–41. 24 indexed citations
14.
Kumar, Sushil, Vineet Ahuja, Mari Jeeva Sankar, Atul Kumar, & Alan C. Moss. (2011). Efficacy of Curcumin (turmeric) in the treatment of Inflammatory Bowel Disease: A systematic review. Inflammatory Bowel Diseases. 17. S16–S16.
15.
Lahiff, Conor, Sunanda V. Kane, & Alan C. Moss. (2011). Drug development in inflammatory bowel disease: The role of the FDA. Inflammatory Bowel Diseases. 17(12). 2585–2593. 11 indexed citations
16.
Cullen, Garret, Byron P. Vaughn, Awais Ahmed, et al.. (2011). Abdominal phlegmons in Crohnʼs disease: Outcomes following antitumor necrosis factor therapy. Inflammatory Bowel Diseases. 18(4). 691–696. 39 indexed citations
17.
Moss, Alan C., Gregory M. Jacobson, Lauren Walker, et al.. (2008). SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer. Clinical Cancer Research. 15(1). 274–283. 47 indexed citations
18.
Kokkotou, Efi, Alan C. Moss, Daniel Torres, et al.. (2008). Melanin-concentrating hormone as a mediator of intestinal inflammation. Proceedings of the National Academy of Sciences. 105(30). 10613–10618. 50 indexed citations
19.
Moss, Alan C. & Mark A. Peppercorn. (2007). The risks and the benefits of mesalazine as a treatment for ulcerative colitis. Expert Opinion on Drug Safety. 6(2). 99–107. 46 indexed citations
20.
Kokkotou, Efi, Daniel Torres, Alan C. Moss, et al.. (2006). Corticotropin-Releasing Hormone Receptor 2-Deficient Mice Have Reduced Intestinal Inflammatory Responses. The Journal of Immunology. 177(5). 3355–3361. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter Stokkers Breakdown of academic impact, for papers by Bas Oldenburg Breakdown of academic impact, for papers by Rupert W. Leong Breakdown of academic impact, for papers by Jae Hee Cheon Breakdown of academic impact, for papers by Miquel Sans Breakdown of academic impact, for papers by Michael Scharl Breakdown of academic impact, for papers by Fernando Magro Breakdown of academic impact, for papers by Morten H. Vatn Breakdown of academic impact, for papers by Minhu Chen Breakdown of academic impact, for papers by Richard J. Grand
Rankless by CCL
2026